Entera Bio Ltd.
ENTX· Nasdaq
Released Aug 11, 2022, before the open
10-Q filed Aug 11, 2022, 42 days after period end · 0001178913-22-003056
| Metric | Q2 2022 | Q2 2021 | Q2 2020 | Q2 2019 |
|---|---|---|---|---|
| Revenue | $44.00K | $109.00K | $52.00K | $74.00K |
| Net Income | -$3.19M | -$2.58M | -$3.19M | -$1.37M |
| EPS Diluted |
Entera Bio Ltd. · CIK 1638097 · Engraved from SEC EDGAR
| $0.11 |
| $0.10 |
| $0.17 |
| $0.12 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.